What bioAffinity Technologies’ $4m financing means for CyPath Lung growth
bioAffinity Technologies closes $4 million financing as CyPath Lung sales grow. Examine dilution, cash runway and commercial expansion.
Medical Devices & Diagnostics
Pharma & Biotech
Verda Healthcare joins forces with AstranaCare in two states, but how much growth can the deal deliver?
Verda Healthcare partners with AstranaCare in Texas and Arizona ahead of Medicare enrollment. Discover the network and growth implications.
Pharma & Biotech
ProCare Injury Specialists reaches 14 Texas clinics, but Waco tests a bigger accident-care strategy
ProCare Injury Specialists adds Waco as its 14th Texas clinic, extending its integrated accident-care network across Central Texas.
Medical Devices & Diagnostics
Cizzle Bio launches CIZ1B lung cancer blood test in limited Texas commercial rollout
Cizzle Bio launches CIZ1B in Texas as a lung cancer blood test, with wider adoption hinging on clinical validation and reimbursement.
Pharma & Biotech
CVS Health’s compact Houston pharmacy could reveal where America’s drugstores are heading
CVS Health opens a pharmacy-focused Houston store as its smaller format tests whether better access can coexist with stronger retail economics for patients.
Medical Devices & Diagnostics
Novartis bets on Texas as radioligand therapy moves closer to mainstream oncology
RLT demand is rising faster than supply chains can stretch. Novartis’ Texas buildout tests whether precision oncology can scale.